StockStory.org on MSN6 小时
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here ...
Repligen (RGEN) Receives a Buy from Craig-Hallum
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Repligen (RGEN – Research Report). The company’s shares ...
Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 80% Above Its Share Price
Key Insights The projected fair value for Repligen is US$264 based on 2 Stage Free Cash Flow to Equity Repligen ...
Repligen (RGEN) Gets a Buy from Craig-Hallum
Craig-Hallum analyst William Bonello maintained a Buy rating on Repligen (RGEN – Research Report) today. The company’s shares closed yesterday ...
来自MSN5 个月
首席技术官Jürgen Müller将离开SAP执行董事会
（全球 TMT2024 年 9 月 3 日讯）SAP SE 宣布，SAP 监事会已经与首席技术官兼执行董事会成员 Dr.-Ing. J ü rgen M ü ller 达成了一项共同协议。J ü rgen M ü ller ...
来自MSN20 天
Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains?
Repligen (RGEN) shares ended the last trading session 3.7% higher at $174.24. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.
Nasdaq20 天
HRMY vs. RGEN: Which Stock Is the Better Value Option?
(HRMY) and Repligen (RGEN). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies for discovering ...